Wedbush Reiterates Outperform Rating for Karuna Therapeutics (NASDAQ:KRTX)
Wedbush reiterated their outperform rating on shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) in a research report released on Friday, Benzinga reports. They currently have a $253.00 price objective on the stock. Several other equities research analysts also recently issued reports on KRTX. Bank of America cut their target price on shares of Karuna […]
More Stories
Compass Minerals International (NYSE:CMP) Shares Up 5% – Time to Buy?
Shares of Compass Minerals International, Inc. (NYSE:CMP – Get Free Report) rose 5% during trading on Tuesday . The stock...
Linear Price Tops $0.0038 on Exchanges (LINA)
Linear (LINA) traded 4.1% lower against the dollar during the twenty-four hour period ending at 23:00 PM ET on October...
Locus Chain Trading Down 14.8% Over Last Week (LOCUS)
Locus Chain (LOCUS) traded 0.7% lower against the US dollar during the 24 hour period ending at 23:00 PM Eastern...
DigiByte (DGB) Hits 24-Hour Trading Volume of $2.17 Million
DigiByte (DGB) traded 1.6% lower against the US dollar during the 1 day period ending at 23:00 PM ET on...
RichQUACK.com (QUACK) Market Capitalization Achieves $35.12 Million
RichQUACK.com (QUACK) traded 16.9% higher against the US dollar during the 24 hour period ending at 23:00 PM ET on...
Centurion One Day Volume Reaches $7.45 (CNT)
Centurion (CNT) traded up 0.6% against the US dollar during the 1-day period ending at 23:00 PM E.T. on October...